The U.S. Food and Drug Administration approved topical ...
Use patterns of topical calcineurin inhibitors (TCIs) were ...
The COVID-19 Research Database was used to assess ...
Tralokinumab-ldrm (Adbry™) was approved in December 2021 for ...
The efficacy and safety of abrocitinib in atopic ...
For patients with moderate-to-severe atopic dermatitis (AD), the ...
Do probiotic supplements improve the symptoms of atopic ...
Warren R. Heymann, MD, FAAD offers his commentary ...
One controversy over the last several decades is ...
Four members of the DermWorld Editorial Advisory Workgroup ...